Cutting Chemo Heart Risks for Breast Cancer Patients
MONDAY, March 12, 2018 -- Two classes of blood pressure drugs show promise in preventing heart complications caused by chemotherapy for breast cancer, researchers report.
One in four women who receives the chemo drug Herceptin develops potentially dangerous heart problems. However, the drug is highly effective at treating an aggressive form of breast cancer called HER2-positive, the scientists added.
"We don't want to avoid this exceptionally effective treatment just because it might cause damage to the heart," said study chair Dr. Maya Guglin, of the University of Kentucky's Heart and Vascular Institute.
The American Heart Association has warned doctors and patients to consider the heart risks of Herceptin when developing a treatment plan for HER2-positive breast cancer.
Guglin and colleagues found that two classes of drugs -- ACE inhibitors and beta blockers -- did not help protect the hearts of patients who received Herceptin alone.
But they did protect the hearts of patients who also received another chemotherapy drug called doxorubicin before they received Herceptin.
In those patients, heart problems occurred in 37 percent of patients who received ACE inhibitors and 31 percent of those who received beta blockers. That compared with 47 percent of patients who didn't receive either type of drug.
"The data clearly demonstrated that, for patients with HER2-positive breast cancer taking both doxorubicin and Herceptin, adding either an ACE inhibitor or a beta blocker to the treatment regimen can significantly offset the chance of heart problems," Guglin said in a university news release.
While the study offers some clarity about treatment options, Guglin said further research is needed before doctors consider this a new standard of care.
The U.S. National Cancer Institute-funded study was presented Sunday at the annual meeting of the American College of Cardiology in Orlando, Fla. Research presented at meetings is usually considered preliminary until published in a peer-reviewed medical journal.
© 2020 HealthDay. All rights reserved.
Posted: March 2018
Read this next
THURSDAY, Oct. 15, 2020 -- Breast cancer in men is rare. But because it's not often suspected in men, diagnosis often comes only after a tumor has begun to spread throughout the...
MONDAY, Oct. 12, 2020 -- Young women with cancer are at a high risk for employment and financial consequences, a new study finds. "Our study addresses the burden of employment...
MONDAY, Oct. 5, 2020 -- Research following patients for nearly three decades finds that surgery plus radiation beats surgery alone for women with ductal carcinoma in situ (DCIS)...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.